- Drug-Eluting Balloons
- Normal Balloons
- Scoring Balloons
- Cutting Balloons
Percutaneous Transluminal Angioplasty (PTA) Balloons Market is expected to grow at a CAGR of 4% during the forecast period 2023 to 2029. Percutaneous transluminal angioplasty (PTA) is a process carried to treat the peripheral artery disease (PAD) by open up the arteries that are narrowed by plaque. Percutaneous transluminal angioplasty (PTA) is a procedure in which a small flexible catheter with a diameter of only a few millimetres is introduced into an artery and guided to a desired site where the blood vessel has narrowed due to cardiovascular disease. A tiny balloon is inflated at the end of the catheter when it reaches the target place, squeezing the blocking component responsible for the restricted artery against the blood vessel wall and restoring normal blood flow. When the balloon is inflated, the blood vessel opening widens, allowing more blood to flow to the heart. During the procedure, a stent is frequently used to maintain the artery open after the balloon is deflated and removed. Superior technological advancements such as progressive flexibility due to innovations in hydrophilic design, superior hydrophilic coatings, improved performance under high pressure due to added pushability, and robust design reducing friction are expected to drive the global percutaneous transluminal angioplasty balloons market growth during the forecast period. Rising reimbursement coverage for the treatment of cardiac diseases, especially among end-users in developing countries (which have a relatively higher patient population), are some of the factors likely to drive the growth of the global percutaneous transluminal angioplasty balloons market between 2017 and 2025. However, the risk of patient discomfort during balloon inflation and the possibility of restenosis are two factors that are anticipated to limit the worldwide Percutaneous Transluminal Angioplasty (PTA) Balloons Market growth over the forecast period.
Percutaneous Transluminal Angioplasty Pta Balloons Market Summary
Study Period
2022-2028
Base Year
2021
CAGR
4%
Largest Market
North America
Fastest Growing Market
Europe
Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics
Increase in the prevalence of peripheral or coronary artery diseases, development in imaging technologies, recent launch of several percutaneous transluminal angioplasty balloons, and rise in R&D for the manufacturing of advanced technology balloons such as drug-eluting balloons are anticipated to fuel the percutanleous transluminal angioplasty balloons market over the forecast period. However, stringent guidelines for product approval, high cost of PTA balloons, and lack of awareness about advanced PTA balloons in underdeveloped countries may restrain the growth of percutaneous transluminal angioplasty balloons market.
North-America got significant share
Percutaneous Transluminal Angioplasty (PTA) Balloons Market Regional Analysis
Geographically, global percutaneous transluminal angioplasty (PTA) balloons market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America percutaneous transluminal angioplasty balloons market growth driven by rise in prevalence of peripheral and coronary artery diseases, rise in R&D for the innovation of advanced products, and sophisticated healthcare infrastructure in the region. Europe percutaneous transluminal angioplasty balloons market accounted for significant share due to rise in R&D activities by the Europe companies, high adoption of advanced PTA balloons by healthcare professionals, and increase in healthcare expenditure. Asia Pacific percutaneous transluminal angioplasty balloons market is poised to grow at significant rate due to rise in prevalence of coronary and peripheral artery diseases, increase in geriatric population and prevalence of diabetes, rise in medical tourism in Asia Pacific countries are anticipated to propel the market. Latin America percutaneous transluminal angioplasty balloons market has a lucrative growth, which is attributed to expansion of the businesses by the market players, rise in prevalence of artery diseases, and conomic growth. Middle East and Africa percutaneous transluminal angioplasty balloons market expected to present better growth opportunity for market players owing to rise in awareness about PTA balloons in South Africa, and rise in prevalence of artery diseases in Middle East region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The percutaneous transluminal angioplasty (PTA) balloons market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Percutaneous Transluminal Angioplasty Pta Balloons Market Segmentation
Product Type
By Application
- Peripheral Artery Disease
- Coronary Artery Disease
By End User
- Hospitals
- Cardiology Clinics
- Ambulatory Surgical Centers
LOCATION
Geography
Frequently Asked Questions
The key segments covered in the Percutaneous Transluminal Angioplasty (PTA) Balloons Market are: by product type, by application and by end users
The Percutaneous Transluminal Angioplasty (PTA) Balloons Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Europe is the fastest-growing for Percutaneous Transluminal Angioplasty (PTA) Balloons Market
| 1.Executive Summary |
| 2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Introduction |
| 2.1.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Taxonomy |
| 2.2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Route of Administration |
| 2.2.5.Region |
| 3.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Drug-Eluting Balloons |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Normal Balloons |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Scoring Balloons |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Cutting Balloons |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Peripheral Artery Disease |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Coronary Artery Disease |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiology Clinics |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Surgical Centers |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Injection |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Nasal Spray |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drug-Eluting Balloons |
| 10.1.2.Normal Balloons |
| 10.1.3.Scoring Balloons |
| 10.1.4.Cutting Balloons |
| 10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Peripheral Artery Disease |
| 10.2.2.Coronary Artery Disease |
| 10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Cardiology Clinics |
| 10.3.3.Ambulatory Surgical Centers |
| 10.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Injection |
| 10.4.2.Nasal Spray |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drug-Eluting Balloons |
| 11.1.2.Normal Balloons |
| 11.1.3.Scoring Balloons |
| 11.1.4.Cutting Balloons |
| 11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Peripheral Artery Disease |
| 11.2.2.Coronary Artery Disease |
| 11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Cardiology Clinics |
| 11.3.3.Ambulatory Surgical Centers |
| 11.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Injection |
| 11.4.2.Nasal Spray |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drug-Eluting Balloons |
| 12.1.2.Normal Balloons |
| 12.1.3.Scoring Balloons |
| 12.1.4.Cutting Balloons |
| 12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Peripheral Artery Disease |
| 12.2.2.Coronary Artery Disease |
| 12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Cardiology Clinics |
| 12.3.3.Ambulatory Surgical Centers |
| 12.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Injection |
| 12.4.2.Nasal Spray |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Drug-Eluting Balloons |
| 13.1.2.Normal Balloons |
| 13.1.3.Scoring Balloons |
| 13.1.4.Cutting Balloons |
| 13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Peripheral Artery Disease |
| 13.2.2.Coronary Artery Disease |
| 13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Cardiology Clinics |
| 13.3.3.Ambulatory Surgical Centers |
| 13.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Injection |
| 13.4.2.Nasal Spray |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Drug-Eluting Balloons |
| 14.1.2.Normal Balloons |
| 14.1.3.Scoring Balloons |
| 14.1.4.Cutting Balloons |
| 14.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Peripheral Artery Disease |
| 14.2.2.Coronary Artery Disease |
| 14.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Hospitals |
| 14.3.2.Cardiology Clinics |
| 14.3.3.Ambulatory Surgical Centers |
| 14.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Injection |
| 14.4.2.Nasal Spray |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.R. Bard, Inc. (U.S.) |
| 15.2.2.Cook Medical, Inc. (U.S.) |
| 15.2.3.Abbott, Inc. (U.S.) |
| 15.2.4.Cardinal Health, Inc. (U.S.) |
| 15.2.5.Boston Scientific Corporation (U.S.) |
| 15.2.6.Spectranetics Corporation (Philips Holding USA Inc.) (U.S.) |
| 15.2.7.Medtronic Plc (Ireland) |
| 15.2.8.SurModics Inc. (U.S.) |
| 15.2.9.ENDOCOR GmbH (Germany) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- R. Bard, Inc. (U.S.)
- Cook Medical, Inc. (U.S.)
- Abbott, Inc. (U.S.)
- Cardinal Health, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Spectranetics Corporation (Philips Holding USA Inc.) (U.S.)
- Medtronic Plc (Ireland)
- SurModics Inc. (U.S.)
- ENDOCOR GmbH (Germany)